Pioneering Technology

Biosensors International operates globally, offering interventional devices and solutions for patients living with Coronary Artery Disease. We are proud of our track record and our continued innovation in the development of next-generation medical technologies, that make a difference to patients’ lives around the world.

Our global commercial teams together with a strong network of distributors, present and deliver our products where they can be of the greatest benefit. Complementing our established cardiovascular presence, our endovascular devices have been launched recently to offer more solutions for patients whose lives we touch.

Pioneering spirit led to Biosensors International developing its own Proprietary Technology in Biolimus A9™. The only limus drug designed specifically for coronary stent applications. BA9™ coated DES and DCS platforms, started a new stent generation that provides treatment solutions for previously neglected patients.

CARDIOVASCULAR PRODUCTS

In the cardiovascular arena we are focused on the development, manufacture and commercialization of drug-eluting stents, drug coated stents and bare metal stents as well as angioplasty catheters for the treatment of coronary artery disease.

Drug Coated Stents (DCS)

BioFreedom Ultra
BioFreedom

 

Drug-Eluting Stents (DES)

v352-wolf_0.png
Biomatrix Neoflex

 

Bare Metal Stents (BMS)

Chroma

 

Balloon dilatation catheters

Powerline
Rise NC

 

Drug Eluting Balloons (DEB)

Biostream

 


ENDOVASCULAR PRODUCTS

Our Endovascular product offering compromises 2 DEBs. BioStream™ for coronary artery disease, BioPath™ for peripheral artery disease, providing solutions for below the knee and superficial femoral artery interventions.

Below the knee

BioFreedom
 

Superficial Femoral Artery

BioFreedom

 


STRUCTURAL HEART
The ALLEGRA™ TAVI System TF is a catheter-based transfemoral heart valve system. It is indicated for the treatment of severe calcified aortic valve stenosis in high risk patients with elevated surgical risk or in patients with a symptomatic degeneration of an aortic valve bioprosthesis.
 

Transcatheter Heart Valve

BioFreedom
 

 


11881-000-EN - Rev.03

CAUTION: Please note that the following pages are exclusively reserved for Health Care Professionals in countries with applicable health authority product registrations. To the extent this site contains information intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions. Please contact your Biosensors representative for availability or the products and registration status.

The law restricts these devices to sale by or on the order of a physician. Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.

Biosensors’ interventional cardiology products, including BioMatrix Flex™, BioMatrix NeoFlex™, BioMatrix™ Alpha, BioFreedom™, BioFreedom™ Ultra, Chroma™, BioStream™, BMX-J®, BioPath™, Powerline™, RISE™ NC, are not available for sale in the United States and certain other countries.

BioMatrix, BioMatrix Flex, BioMatrix NeoFlex, BioMatrix Alpha, BioFreedom, BioFreedom Ultra, Chroma, BioStream, BMX-J, BioPath, Juno, S-Stent, Powerline, Rise NC and Quadrature Link are trademarks or registered trademarks of Biosensors International Group, Ltd. All other cited trademarks are the property of their respective owners.